Advances in endoscopic sinus surgery technique and technology have provided the otolaryngologist with a wide array of surgical options for the management of nasal and paranasal sinus diseases that were once limited to procedures requiring invasive surgery. We describe the case of a patient with a chondrosarco ma of the posterior nasal septum that was resected endoscopica lly. There have been fewer than 30 reports in the Englishlanguage literature of chondrosarcomas arising at this location, and the reported approaches to surgical excision in these cases involved craniofacial procedures, facia l degloving.facial splitting, and maxillectomy techniques. Until now, no case of endoscopic removal has been reported.
Introduction
Chond rosarcomas of the head and neck are uncommon . A lO-year review of355,019 cases of head and neck cancers compiled in the National Canc er Database revealed that only 400 of these tumors (0.1 %) were chondrosarcomas.' A review by Rassekh et al found that there ha ve been fewer than 30 reports in the En glish-language literature of chondrosa rcomas arising from the nasal septum. ' Sur gical resection is generally regarded as the primary treatm ent for head and neck chondrosarcomas . Th e only surgical approaches that have been reported thu s far are cra niofa cial procedures, fac ial degloving, facial splitting, and various types of maxillectom y.2-7 Until now, there had been no rep ort of endoscopic resection of a nasal septal chondrosarco ma . In this article , we report our use of this techn ique in a patient with a nasal septal chondrosarco ma. Case report A 73-year -old woman came to us with a 5-month history of a pro gressive right-sided nasal obstruc tion , postnasal drip, and a thick mucoid nasal disch arge. On exa mination, the patient was noted to have an obstructing mass in the posterior portion of the right nasal cavity that appe ared to be aris ing from the posterior septum (figure 1). Computed tomography (CT) revealed the presence of a 2.8 x 2.4 x 3.3-c m soft-tissue mass that was centere d on the posterior sep tum. Th e mass bowed the medial wall of the right maxill ary sinus and extended into the anterior nasoph arynx (figure 2). It ero ded the floor of the righ t sphenoid sinus, and there was a small amo unt of extension into the sphenoid sinus. However, no skull base erosi on was identified.
An intranasal endoscopic biopsy of the septal mass was performed. Frozen-section eva luation revealed an atypical car tilaginous neopl asm with tapering chondrocytes and a grade 2 cellularity with nucl ear atypia (figure 3). In addition, the presence of scattered mitotic figures and a large focus of necrosis led to the pathologic diagnosis of a chondrosarcoma.
The chondrosarcoma' s relative ly small size, intranasal location , and lack of skull base invas ion led us to attempt an intr anasal endoscopic resection as opposed to a traditional surg ical approach. The patient was position ed and draped in a fashion similar to that used during endoscopic sinus surgery. Decongestion was administered with oxymetazoline and 1% lidocaine with 1:100,000 epinephrine. Thenasal cavity was visualized through a 0°Storz Hopkins endosc ope attached to a video unit. Tru-Cut forc eps were used to rese ct the middl e turbin ate and expose the chondrosarco ma . A Freer eleva tor was then used to obtain a clear plane of dissection from the adjacent nasal muc osa. The chondrosarcom a was left tethered to the posterior nasal septum. A l-cm margin along the septum was obtained by remo ving the posterio r septum from the face of the sphenoid sinus to the nasal floo r with the Tru-Cut forc eps. Th e anterior wall of the sphenoid sinuses was then clearly visible . The faces of both sphenoid sinuses were removed with Kerrison 's forceps and a 327 MATIHEW S, WHANG , SMITH Figure 1 . Nasa l endoscopy of the right nasal cavity shows the mass arising fro m the posterior nasal septum.
Xomed microd ebrider. No further tumor was visualized, and multiple frozen sections revealed a clear surgical margin.
The patient was discharged home on postoperative day 1. One week later, she was hospitalized for 2 days after undergoing ligation of the left sphenopalatine artery to control epistaxis. Since then, surveillance of the posterior nasal cavity has been easily accomplished by office-b ased rigid endoscopy (figure 4). The patient has done well 27 months after surgery, and she shows no clinical evidence of recurrent disease.
Discussion
Since Wigand ' s use of the optical endoscope for intranasal surgery, otolaryngologists have adopted new advances in technology that provide better illumin ation and visualization for the management of nasal and paranasal sinus diseases. Modern endoscopic sinus surgery equipment allows the otola ryngologi st to take minimally invasive intranasal approaches to disease proce sses that were once limited to treatment by external appro aches. Our report of a nasal septal chondros arcoma resected via an intranasal approach with endoscopic techniques and equipment is testimony to the technologic impro vements in fiberopti c endoscope s, monitoring system s, and endoscopic surgical techniqu e. All previously published reports of surgica l excisions of nasal septal chondrosarcomas involved craniofacial procedures, facial degloving, facial splitting, and various types of maxillectomy . [2] [3] [4] [5] [6] [7] Chondro sarcomas are malignant tumors of cartilaginous origin. They occur infrequently in the head and neck region, and they are extremely rare in the nasal septum. In fact; the largest series of nasal septal chondros arcom as reported to date numbered only six patients.' Symptom s are typically caused by mass effect or erosion of adjacent structures. Sinon asal chondro sarcoma s have been noted 328 Figure 2 . Coronal-plane CT shows that the mass is centered on the posterior nasal septum.
to cause nasal obstruction , headache , and cranial neuropathies.
CT usuall y demon strates a hypodense mass with areas of spotty calcification, and it can determine the extent of bony destruction. Magnetic resonance imaging has been shown to accurately define tumor extent and intracranial invol vement. Histopathologic specimens are needed to make a definitive diagnosis and to grade a tumor on the basis of its histologic characteri stics (i.e., grade 1,2, or 3, depending on nuclear size, atypia, mitot ic activity, and cellularity). A correlation has been made between lowgrade chondrosarcomas and longer sur vival.I-' The primary treatment of head and neck chondrosarcomas is radical surgical resection with clear margin s. The use of chemo-and radiotherapy is limited.
Our review of the literature on nasal septal chondrosarcomas revealed that they are typicall y diagnosed at a late stage because of the nonspecific nature of their Dry mouth due to radiation-induced xerostomia is not only uncomfortable, it can lead to oral health complications. ' With the longest record of clinically proven efficacy and time proven safety of any prescription dry mouth treatment, Salagen Tablets can restore patients' natural protective saliva. Use of Salagen Tablets is supported by:
• More than 23,000,000 patient-days of therapy'
• Consistent, statistically significant improvements • Published proof, including articles in such leading journals in both objective and subjective parameters" as New England In long-term treatment were two pati ents with underlying car diovascular disease of whom one experienced a myocardial infarct and anotheran episode of syncope,The association with drugis uncertain, Sjogren's SyndromePatient s: In controll ed studies, 376 patients received pilocarpine, of who m 5% were men and 95% were women. Race distribution was 84% Caucasian, 9% Orient al, 3% Bl ack, and 4%of oth er origin, Mean age was 55 years, The maj orityof patient s were between 40 and 69 years (70%), 16% were 70 years and older and 14% were younger than40years ofage, Ofthese patients, 161/629 (89/376receiving pilocarpine) wereovertheage of65yea rs.Theadverse eventsreport edby those over 65 years and those 65 years and younger were comparabl e except for notable trends for urinary frequency, diarrhea, and diu iness. The incidences of urinary frequency and diarrhea in the elderly were about doublethoseinthenon-el derl y,Theinci denceofdizzi nesswasabout three times as hi gh in the elder ly as in the non-elderly. These adverse experiences were not considered to be serious. In the 2 placebo-controlled studies, the most common adverse events related to drug use were sweating, urinary frequency, chills, and vasodi latation (flushing Renal Insufficiency: The pharmacokinet ics of orally administered pil ocarpine in patientswith renal and hepatic disease is not known. . symptoms. Rep ort s of the size of chondrosarco mas on ini tial evaluation have varied . We were fortunate to have · di scovered our patient ' s nasal septal chondrosarcoma at a relati vely ea rly stage. Four fac tors led us to offer our patient thi s minimally inv asive endoscopic resecti on approach: (1) the sma ll size of the tum or, (2) the location of the tumor, wh ich afforded excelle nt vis ualiza tion with endoscopic equipment, (3) the lack of skull base involvement , and (4) the ability to eas ily co nduct surve illa nce for rec urrent disease in the office with rigid endos copy. Althoug h we were able to end oscopica lly acc omplish a co mplete tumor resecti on with cle ar margins, we did obtain preoperati ve co nse nt to switch to a traditional maxill ectom y if the need had arisen.
We certai nly do not advocate th at endoscopic remo val of nasal septal chondrosarcomas be perfor me d routinely. Nevertheless, in very car efully selec ted patients (e .g., tho se with sma ll tumors and a lack ofskull base invasi on), endoscopic resection offers a les s-invasive mean s of surg ica l excision.
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